• Financial performance and seasonality: The sequential decline in quarterly profit was attributed to seasonality where 45% of revenue is generated in the first half and 55% in the second half, while year-on-year profitability grew by 35% with 15% constant currency revenue growth.
• EBITDA margin guidance: Sagility maintained its full-year adjusted EBITDA margin guidance at 24% to 25%, having delivered a 24% adjusted EBITDA margin and a 13.7% adjusted profit in the first quarter.
• Deal wins and outlook: The company secured $35 million in annual revenue deals during the quarter and reaffirmed its full-year constant currency revenue guidance of low double-digit growth.
• AI and diversification strategy: Management confirmed it will remain 100% focused on the US healthcare market without diversifying, embedding AI directly into its operational solutions to drive outsourcing efficiency.
• Kaseer acquisition contribution: The Kaseer acquisition is targeted to generate $5.5 million to $6 million in revenue this year, providing additional growth on top of the guided double-digit organic expansion.